TipRanks
Alpha Tau (IL:DRTS)
TASE:DRTS
Israel Market
DRTS
Alpha Tau
RESEARCH TOOLSreports

Alpha Tau (DRTS) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

DRTS Analyst Ratings

Moderate Buy
3Ratings
Moderate Buy
2 Buy
1 Hold
0 Sell
Based on 3 analysts giving stock ratings to
Alpha
Tau
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DRTS Stock 12 Month Forecast

Average Price Target

5,465.94
Based on 3 Wall Street analysts offering 12 month price targets for Alpha Tau in the last 3 months. The average price target is 5,465.94 with a high forecast of 9,109.90 and a low forecast of 2,429.31. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2428":"2,428","5769":"5,769","9110":"9,110","4098.5":"4,098.5","7439.5":"7,439.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9109.90185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">9K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5465.94111,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">5.47K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2429.30716,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">2.43K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2428,4098.5,5769,7439.5,9110],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4280,4651.530911538462,5023.061823076923,5394.592734615385,5766.1236461538465,6137.654557692308,6509.18546923077,6880.71638076923,7252.247292307693,7623.778203846154,7995.309115384616,8366.840026923077,8738.37093846154,{"y":9109.90185,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4280,4371.226239230769,4462.452478461539,4553.678717692308,4644.9049569230765,4736.131196153846,4827.357435384615,4918.583674615385,5009.809913846154,5101.036153076923,5192.262392307692,5283.488631538461,5374.71487076923,{"y":5465.94111,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4280,4137.639012307693,3995.2780246153848,3852.917036923077,3710.556049230769,3568.1950615384612,3425.834073846154,3283.473086153846,3141.112098461538,2998.7511107692308,2856.390123076923,2714.029135384615,2571.6681476923077,{"y":2429.30716,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4401,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4401,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4280,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target9,110Average Price Target5,466Lowest Price Target2,429
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on IL:DRTS
Lukas Shumway
Barclays
Barclays
5,162.28→9,109.9
Buy
―
Reiterated
09/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (NYSE: PHR), Alpha Tau (NASDAQ: DRTS) and Fortrea Holdings Inc. (NASDAQ: FTRE)
H.C. Wainwright Analyst forecast on IL:DRTS
Yi Chen
H.C. Wainwright
H.C. Wainwright
4,858.61
Buy
―
Reiterated
09/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Invivyd (NASDAQ: IVVD) and Alpha Tau (NASDAQ: DRTS)
Piper Sandler Analyst forecast on IL:DRTS
Jason Bednar
Piper Sandler
Piper Sandler
2,429.31
Hold
―
Assigned
08/11/26
Alpha Tau Medical Ltd (DRTS) Receives a Hold from Piper Sandler
Ladenburg Thalmann & Co. Analyst forecast on IL:DRTS
Jeffrey Cohen
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
4,251.29
Buy
―
Reiterated
05/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (NASDAQ: BNTX), Personalis (NASDAQ: PSNL) and Alpha Tau Medical Ltd (NASDAQ: DRTS)
Citi Analyst forecast on IL:DRTS
Yigal Nochomovitz
Citi
Citi
2,125.64→2,732.97
Buy
―
Assigned
03/10/26
Alpha Tau price target raised to $9 from $7 at CitiAlpha Tau price target raised to $9 from $7 at Citi
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on IL:DRTS
Lukas Shumway
Barclays
Barclays
5,162.28→9,109.9
Buy
―
Reiterated
09/02/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (NYSE: PHR), Alpha Tau (NASDAQ: DRTS) and Fortrea Holdings Inc. (NASDAQ: FTRE)
H.C. Wainwright Analyst forecast on IL:DRTS
Yi Chen
H.C. Wainwright
H.C. Wainwright
4,858.61
Buy
―
Reiterated
09/01/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (NASDAQ: PRCT), Invivyd (NASDAQ: IVVD) and Alpha Tau (NASDAQ: DRTS)
Piper Sandler Analyst forecast on IL:DRTS
Jason Bednar
Piper Sandler
Piper Sandler
2,429.31
Hold
―
Assigned
08/11/26
Alpha Tau Medical Ltd (DRTS) Receives a Hold from Piper Sandler
Ladenburg Thalmann & Co. Analyst forecast on IL:DRTS
Jeffrey Cohen
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
4,251.29
Buy
―
Reiterated
05/12/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (NASDAQ: BNTX), Personalis (NASDAQ: PSNL) and Alpha Tau Medical Ltd (NASDAQ: DRTS)
Citi Analyst forecast on IL:DRTS
Yigal Nochomovitz
Citi
Citi
2,125.64→2,732.97
Buy
―
Assigned
03/10/26
Alpha Tau price target raised to $9 from $7 at CitiAlpha Tau price target raised to $9 from $7 at Citi
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ZVRAZevra Therapeutics
ELVNEnliven Therapeutics
DFTXDefinium Therapeutics
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alpha Tau

3 Months
Yi ChenH.C. Wainwright
Success Rate
21/23 ratings generated profit
91%
Average Return
+27.66%
Copying Yi Chen's trades and holding each position for 3 Months would result in 91.30% of your transactions generating a profit, with an average return of +27.66% per trade.
1 Year
Yi ChenH.C. Wainwright
Success Rate
22/23 ratings generated profit
96%
Average Return
+129.27%
Copying Yi Chen's trades and holding each position for 1 Year would result in 95.65% of your transactions generating a profit, with an average return of +129.27% per trade.
2 Years
Yi ChenH.C. Wainwright
Success Rate
23/23 ratings generated profit
100%
Average Return
+264.74%
Copying Yi Chen's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +264.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DRTS Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
2
5
5
4
1
Buy
6
5
7
5
6
Hold
2
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
11
13
10
8
In the current month, DRTS has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. DRTS average Analyst price target in the past 3 months is 5,465.94.
Each month's total comprises the sum of three months' worth of ratings.

DRTS Financial Forecast

DRTS Earnings Forecast

Next quarter’s earnings estimate for DRTS is -44.25 with a range of -48.17 to -39.14. The previous quarter’s EPS was -150.52. DRTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DRTS has Performed in-line its overall industry.
Next quarter’s earnings estimate for DRTS is -44.25 with a range of -48.17 to -39.14. The previous quarter’s EPS was -150.52. DRTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year DRTS has Performed in-line its overall industry.
No data currently available

DRTS Sales Forecast

Next quarter’s sales forecast for DRTS is 73.15M with a range of 0.00 to 150.52M. The previous quarter’s sales results were 0.00. DRTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DRTS has Performed in-line its overall industry.
Next quarter’s sales forecast for DRTS is 73.15M with a range of 0.00 to 150.52M. The previous quarter’s sales results were 0.00. DRTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year DRTS has Performed in-line its overall industry.

DRTS Stock Forecast FAQ

What is IL:DRTS’s average 12-month price target, according to analysts?
Based on analyst ratings, Alpha Tau’s 12-month average price target is 5,465.94.
    What is IL:DRTS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for IL:DRTS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Alpha Tau a Buy, Sell or Hold?
        Alpha Tau has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 1 hold ratings and 0 sell ratings.
          What is Alpha Tau’s share price target?
          The average share price target for Alpha Tau is 5,465.94. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is 9,109.90 ,and the lowest forecast is 2,429.31. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Alpha Tau?
            Alpha Tau’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 3 Wall Streets Analysts.
              How can I buy shares of Alpha Tau?
              To buy shares of IL:DRTS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.